Five New Therapies or Just One New Treatment? A Critical Look at Immune Checkpoint Inhibition in Urothelial Cancer
Author(s) -
Amishi Y. Shah,
Jianjun Gao,
Arlene O. SiefkerRadtke
Publication year - 2017
Publication title -
immunotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.127
H-Index - 48
eISSN - 1750-7448
pISSN - 1750-743X
DOI - 10.2217/imt-2017-0073
Subject(s) - durvalumab , avelumab , atezolizumab , nivolumab , medicine , immune checkpoint , pembrolizumab , cancer research , cancer , immune system , immunotherapy , oncology , immunology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom